Dr. Bas Trietsch is the Chief Technology Officer and Co-Founder at MIMETAS, a company working to contribute to groundbreaking therapies with their screenable, physiologically relevant 3D human disease models.
With a robust background in biopharmaceutical sciences and a passion for innovation, Bas plays a crucial role in advancing MIMETAS’ microfluidic and biological platforms for drug discovery and preclinical research. His expertise and leadership continue to drive MIMETAS’ mission to transform the future of medicine through advanced biotechnology.